Recommendations on the use of live, attenuated influenza vaccine (FluMist®): Supplemental Statement on Seasonal Influenza Vaccine for 2011-2012: An Advisory Committee Statement (ACS): National Advisory Committee on Immunization (NACI)†

. 2011 Nov 30;37(ACS-7):1–77. doi: 10.14745/ccdr.v37i00a07

LAIV should be administered according to the following schedule:
Age Group	Vaccination Status	Dosage Schedule
Children* (2 to 8 years of age)	Not previously vaccinated with seasonal influenza vaccine	Two doses (0.2 mL^a each, at least 4 weeks apart)
Children* (2 to 8 years of age)	Previously vaccinated with seasonal influenza vaccine	Single dose (0.2 mL^a)
Children, adolescents and adults 9 to 59 years of age	Not applicable	Single dose (0.2 mL^a)

^a Administer as 0.1 mL per nostril

* LAIV is not recommended in persons <2 years of age due to increased risk of wheezing (See Adverse Events).